Literature DB >> 19335064

Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions.

Michael Doumas1, Daqing Guo, Vasilios Papademetriou.   

Abstract

BACKGROUND: The role of the carotid baroreflex in blood pressure regulation has been known for a long time but its effects were thought to be short lived. Recent data indicate that stimulation of carotid baroreceptors may lower blood pressure not only for short periods of time, but also in the long run. OBJECTIVE/
METHODS: Recent advances in technology permitted the development of a new device (Rheos) that addresses problems with older devices. Several questions remain to be addressed before Rheos can be used widely, and several potential clinical applications remain to be clarified. This review examines these issues and comprehensively describes this therapeutic approach. RESULTS/
CONCLUSIONS: The carotid baroreceptor reflex is probably not completely in control of blood pressure. Baroreflexes are one of many control systems acting in concert.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335064     DOI: 10.1517/14728220902780185

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  14 in total

Review 1.  Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.

Authors:  Michael Doumas; Charles Faselis; Costas Tsioufis; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 2.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

Review 3.  Methods of assessing vagus nerve activity and reflexes.

Authors:  Mark W Chapleau; Rasna Sabharwal
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

4.  Association Between Systemic Inflammation, Carotid Arteriosclerosis, and Autonomic Dysfunction.

Authors:  Sven Rupprecht; S Finn; D Hoyer; A Guenther; O W Witte; T Schultze; M Schwab
Journal:  Transl Stroke Res       Date:  2019-05-16       Impact factor: 6.829

Review 5.  Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease.

Authors:  François M Abboud; Sailesh C Harwani; Mark W Chapleau
Journal:  Hypertension       Date:  2012-02-13       Impact factor: 10.190

Review 6.  Renal denervation and treatment of hypertension.

Authors:  Ralph Knöll
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

7.  What price for blood pressure control?

Authors:  Stephen C Textor
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-10       Impact factor: 3.738

8.  Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension.

Authors:  Vasilios Papademetriou; Michalis Doumas; Konstantinos Tsioufis
Journal:  Int J Hypertens       Date:  2011-03-30       Impact factor: 2.420

9.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

10.  Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies.

Authors:  Vasilios Papademetriou; Konstantinos Tsioufis; Alan Gradman; Henry Punzi
Journal:  Int J Hypertens       Date:  2011-06-01       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.